132389 <common-name>Chymostatin</common-name> <description>Chymostatin is an organic compound with the chemical formula C31H41N7O6. Chymostatin belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 607.71 g/mol, Chymostatin is a heavy molecule. In terms of biological activity, it acts as an inhibitor of two recorded protein targets: Amidase (pam) and Chymase (CMA1).</description> <cas>9076-44-2</cas> <pubchem-id>443119</pubchem-id> <chemical-formula>C31H41N7O6</chemical-formula> <weight nil="true"/> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-13T21:02:19Z</created-at> <updated-at type="dateTime">2026-05-14T17:12:49Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id>DB01683</drugbank-id> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)C[C@H](NC(=O)[C@@H](NC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O)C1CCNC(=N)N1)C(=O)N[C@@H](CC1=CC=CC=C1)C=O</moldb-smiles> <moldb-formula>C31H41N7O6</moldb-formula> <moldb-inchi>InChI=1S/C31H41N7O6/c1-19(2)15-24(27(40)34-22(18-39)16-20-9-5-3-6-10-20)35-28(41)26(23-13-14-33-30(32)36-23)38-31(44)37-25(29(42)43)17-21-11-7-4-8-12-21/h3-12,18-19,22-26H,13-17H2,1-2H3,(H,34,40)(H,35,41)(H,42,43)(H3,32,33,36)(H2,37,38,44)/t22-,23?,24-,25-,26-/m0/s1</moldb-inchi> <moldb-inchikey>MRXDGVXSWIXTQL-HYHFHBMOSA-N</moldb-inchikey> <moldb-average-mass type="decimal">607.712</moldb-average-mass> <moldb-mono-mass type="decimal">607.311832068</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>-0.39</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM128282</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(2S)-2-({[(S)-(2-imino-1,3-diazinan-4-yl)({[(1S)-3-methyl-1-{[(2S)-1-oxo-3-phenylpropan-2-yl]carbamoyl}butyl]carbamoyl})methyl]carbamoyl}amino)-3-phenylpropanoic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer">5880</paper-count> <sync-id>CED0004102</sync-id> <structure-inchikey>MRXDGVXSWIXTQL-HYHFHBMOSA-N</structure-inchikey> <structure-fingerprint>400000000000000000018200000004200000000000000000000000000000000000000010000448000000000000000000040000000000000000000000000000080000000000000004000000040101040000200000008002000000020080000100000000000100000000001040000000000000000200000000000000000008001000000000c0200000800002200010000080000000100100000000000000000000000000002004000000001000080000000000000000000400002000000000000000003000000000000000008100000010000000100000008000000220000000000000800000000900002440000000000400000000000000000400020080000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAsAAAALgAAAIABBgBgAAAAAQMGAGAAAAAD AQYAYAAAAAEDBgBgAAAAAgIGIDQAAAACAQQHAGgAAAADAgEGACgAAAADBAgA KAAAAAMCBiA0AAAAAQEEBwBoAAAAAwIBBgAoAAAAAwQIACgAAAADAgcAaAAA AAMCAQYgNAAAAAEBBAYAYAAAAAICBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGACgAAAADBAgAaAAAAAMB AQgAKAAAAAMCBgBgAAAAAwEGAGAAAAACAgYAYAAAAAICBwBoAAAAAwIBBgAo AAAAAwQHAGgAAAADAgEHAGgAAAADAgEGACgAAAADBAgAKAAAAAMCBwBoAAAA AwIBBiA0AAAAAQEEBgBgAAAAAgIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMD AQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQYAaAAAAAMDAQgAKAAAAAMC CwABAAECAAEDAAMEAAQFAAUGIAYHKAIGCAAICQAJCiAKCygCCgwgDA0ADQ4A Dg8ADxBoDBARaAwREmgMEhNoDBMUaAwNFQAVFiAVFygCCBgAGBkAGRoAGhsA GxwgHB0oAhweIAQfAB8gKAIfISAhIgAiIwAjJAAkJWgMJSZoDCYnaAwnKGgM KCloDCIqACorCAIUD2gMHhgAKSRoDEIDAAAABhAREhMUDwYZGhscHhgGJSYn KCkkFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T04:49:03Z</structure-indexed-at> </compound>